Viatris

Viatris UK Healthcare is the UK subsidiary of Viatris Inc., a global pharmaceutical company formed in 2020 through the combination of Mylan and Pfizer's Upjohn division.

Operating from sites in Hertfordshire, Cambridge, and Sandwich, Kent, the UK entity carries out formulation and device research and development, pharmacovigilance, regulatory affairs, and commercial operations across a portfolio of nearly 250 generic, branded, and biosimilar medicines.

UK therapeutic areas include gastroenterology, dermatology, respiratory, and women's health.